IL324797A - תכשירים חדשים לטיפול במחלות דלקתיות - Google Patents

תכשירים חדשים לטיפול במחלות דלקתיות

Info

Publication number
IL324797A
IL324797A IL324797A IL32479725A IL324797A IL 324797 A IL324797 A IL 324797A IL 324797 A IL324797 A IL 324797A IL 32479725 A IL32479725 A IL 32479725A IL 324797 A IL324797 A IL 324797A
Authority
IL
Israel
Prior art keywords
acid
disease
inflammatory
dfo
metal
Prior art date
Application number
IL324797A
Other languages
English (en)
Inventor
Biopharma Concenter
Dror Chevion
Itzchak Angel
Vinokur Vladimir
Original Assignee
Biopharma Concenter
Dror Chevion
Itzchak Angel
Vinokur Vladimir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharma Concenter, Dror Chevion, Itzchak Angel, Vinokur Vladimir filed Critical Biopharma Concenter
Publication of IL324797A publication Critical patent/IL324797A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
IL324797A 2023-05-22 2024-05-22 תכשירים חדשים לטיפול במחלות דלקתיות IL324797A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363468018P 2023-05-22 2023-05-22
PCT/IB2024/054991 WO2024241250A2 (en) 2023-05-22 2024-05-22 Novel composition for treatment of inflammatory related disorders

Publications (1)

Publication Number Publication Date
IL324797A true IL324797A (he) 2026-01-01

Family

ID=93590398

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324797A IL324797A (he) 2023-05-22 2024-05-22 תכשירים חדשים לטיפול במחלות דלקתיות

Country Status (8)

Country Link
EP (1) EP4716530A2 (he)
JP (1) JP2026521351A (he)
KR (1) KR20260015873A (he)
CN (1) CN121793956A (he)
AU (1) AU2024275726A1 (he)
IL (1) IL324797A (he)
MX (1) MX2025013957A (he)
WO (1) WO2024241250A2 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ572226A (en) * 2006-04-18 2011-05-27 Ekr Therapeutics Inc Pre-mixed, ready-to-use IV bolus compositions comprising nicardipine and methods of use
EP3189836B1 (en) * 2009-08-19 2024-01-17 Mordechai Chevion Desferrioxamine-metal complexes for the treatment of immune-related disorders
CA2971824A1 (en) * 2014-12-22 2016-06-30 Mordechai Chevion New metal complexes of nocardamine and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
CN121793956A (zh) 2026-04-03
WO2024241250A3 (en) 2025-01-02
JP2026521351A (ja) 2026-06-30
MX2025013957A (es) 2026-03-02
AU2024275726A1 (en) 2025-12-11
EP4716530A2 (en) 2026-04-01
KR20260015873A (ko) 2026-02-03
WO2024241250A2 (en) 2024-11-28

Similar Documents

Publication Publication Date Title
US20230181597A1 (en) Metal complexes of nocardamine and their use in pharmaceutical compositions
AU2016244189B2 (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders
CN108884053A (zh) 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法
JP6185575B2 (ja) 皮膚炎症性疾患の治療方法
US10751316B2 (en) Pharmaceutical composition for treating inflammation and pain
JP2023089077A (ja) N-アセチル又はn-アシルアミノ酸を含むアトピー又は痒み症治療用組成物
EP4716530A2 (en) Novel composition for treatment of inflammatory related disorders
EP2854785B1 (en) Pharmaceutical composition for treating inflammation and pain
AU2013274579B2 (en) Compounds for treating inflammation and pain
HK1238559A1 (en) New metal complexes of nocardamine and their use in pharmaceutical compositions
JP6189944B2 (ja) 炎症及び疼痛を治療するための化合物
US20150306175A1 (en) HSP For Use in Treatment for Imiquimod Related Side Effects